Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.076 | 0.1 |
mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.2 |
mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |